Lv1
40 积分 2025-01-19 加入
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
2个月前
已完结
Effects of Antidiabetic Drugs on Muscle Mass in Type 2 Diabetes Mellitus
2个月前
已完结
Effects of liraglutide on body composition in people living with obesity or overweight: A systematic review
2个月前
已完结
Pharmacokinetics, safety, tolerability and efficacy of cotadutide, a glucagon‐like peptide‐1 and glucagon receptor dual agonist, in phase 1 and 2 trials in overweight or obese participants of Asian descent with or without type 2 diabetes
2个月前
已完结
Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial
3个月前
已完结
Characterizing body composition modifying effects of a glucagon‐like peptide 1 receptor‐based agonist: A meta‐analysis
3个月前
已完结
皖公网安备34019202002308
